These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 854865)

  • 41. The effect of dibromodulcitol (Elobromolr, Mitolactolr, nsc 104 800) on the postoperative recurrences of the Guerin carcinoma of the rat.
    Németh L; Somfai S
    Neoplasma; 1976; 23(1):37-41. PubMed ID: 1272472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic studies on Elobromol in children with brain tumors.
    Paál C; Erdélyi-Tóth V; Pap E; Csáki C; Ferencz T; Schuler D; Borsi JD
    Anticancer Drugs; 1994 Oct; 5(5):539-47. PubMed ID: 7858286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D; Sipos L; Vitanovics D
    Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
    Szende B; Jeney A; Institoris L
    Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trials with the hexitol derivatives in the U.S.
    Chiuten DF; Rozencweig M; Von Hoff DD; Muggia FM
    Cancer; 1981 Feb; 47(3):442-51. PubMed ID: 6784907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer.
    Cummings FJ; Gelman R; Tormey DC; DeWys W; Glick J
    Cancer Clin Trials; 1981; 4(3):253-60. PubMed ID: 7026074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBD.
    Horváth IP; Csetényi J; Kerpel-Fronius S; Hegedüs L; Kanyár B; Eckhardt S
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):163-71. PubMed ID: 3699079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dibromodulcitol and adriamycin +/- tamoxifen in advanced breast cancer.
    Tormey DC; Falkson G; Crowley J; Falkson HC; Voelkel J; Davis TE
    Am J Clin Oncol; 1982 Feb; 5(1):33-9. PubMed ID: 7081136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical controlled trial in advanced breast cancer: CMFV (cyclophosphamide, methotrexate, fluorouracil, vincristine) verus CD (carminomycin, dibromodulcitol).
    Neoplasma; 1982; 29(6):741-7. PubMed ID: 6761595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptotic and mitotic activity in squamous cell carcinoma cells after combined modality treatment with gamma-irradiation and dibromodulcitol.
    Kraxner H; Tamás L; Sáfrány G; Ribári O; Oláh I; Hidvégi E; Répássy G; Szende B
    Cell Biol Int; 2001; 25(7):599-606. PubMed ID: 11448098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Palliative mitolactol treatment of patients with cervical carcinoma in cases of unsuccessful radiotherapy].
    Kozuch-Gdak W
    Nowotwory; 1978 Dec; 28(4):405-7. PubMed ID: 83603
    [No Abstract]   [Full Text] [Related]  

  • 54. The distribution of bromine content of dibromodulcitol in the central nervous system of patients with malignant gliomas.
    Sziklai IL; Afra D; Ordogh M; Institoris L; Kerpel-Fronius S; Szabo E
    Eur J Cancer; 1990 Feb; 26(2):79-82. PubMed ID: 2157475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.
    Falkson G; Gelman RS; Tormey DC; Taylor SG; Falkson HC
    Cancer Treat Rep; 1985; 69(7-8):755-60. PubMed ID: 4016786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rat liver-mediated degradation of dibromodulcitol.
    Csetényi J; Gáti E; Hegedüs L; Horváth IP; Holczinger L
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):881-5. PubMed ID: 4043174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure of alkylating agents to improve induction chemotherapy of oropharyngeal squamous cell cancer.
    Olasz L; Nyárády Z; Németh A; Királyfalvi L; Ember I
    Anticancer Res; 2004; 24(4):2557-61. PubMed ID: 15330214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporation of 3H-dibromodulcitol and 3H-dianhydrodulcitol into ascites tumor cells. Autoradiographic study.
    Kopper L; Lapis K; Institóris L
    Neoplasma; 1976; 23(1):47-52. PubMed ID: 1272473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Polyamines and their significance for control of cancer chemotherapy (author's transl)].
    Nissen E; Dettmer R; Fiedler D; Bodammer M
    Arch Geschwulstforsch; 1980; 50(4):336-40. PubMed ID: 7458581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adjuvant therapy in carcinoma of Waldeyer's ring].
    Síbl O; Pekárek J
    Cesk Otolaryngol; 1982 Jun; 31(3):161-5. PubMed ID: 7116486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.